Revive TherapeuticsRVVTF
13F holders, Q1 2025 (March 31)1holders
0new positions
0sold out
$0.01avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Revive Therapeutics Ltd. (RVVTF) in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holder was FineMark National Bank & Trust ($96).
- Company
- Revive Therapeutics Ltd.
- CUSIP
- 761516103
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| FineMark National Bank & Trust | 0.00% | No change | 10,345 | $96 |
"% of holder's portfolio" is RVVTF's weight in each manager's 13F, not the share of Revive Therapeutics Ltd. the manager owns.